MURINE ASCITES TUMOR CELL GLYCOPROTEINS
鼠腹水肿瘤细胞糖蛋白
基本信息
- 批准号:3165294
- 负责人:
- 金额:$ 19.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-12-01 至 1989-11-30
- 项目状态:已结题
- 来源:
- 关键词:Ehrlich's tumor alpha galactosidase aminoacid analyzer analytical ultracentrifugation antibody basement membrane carbohydrate structure cell membrane disaccharides electron microscopy entactin galactose gel electrophoresis immunofluorescence technique laboratory mouse laboratory rabbit laminin lectin macrophage malignant ascites membrane proteins protein biosynthesis protein metabolism protein sequence protein structure radiotracer surface antigens tissue /cell culture tumor antigens
项目摘要
This research represents a continuation of our studies on
alpha-D-galactosyl-containing glycoproteins present on certain animal cells
and tissues. We will focus attention on the carbohydrate moieties of two
basement membrane and cell surface glycoproteins: laminin and entactin,
both of which contain alpha-D-galactosyl end groups. Laminin is believed
to be present on the surface of highly metastatic cells. Structural and
biosynthetic studies will be conducted on the carbohydrate residues of
these glycoproteins as well as on the alpha-D-galactosyl-terminated
glycoproteins present on the surface of Ehrlich tumor cells. Purified
lectins of known carbohydrate binding specificity, antibodies raised
against murine laminin and against a trisaccharide hapten present as part
of the structure of these glycoproteins, will be employed in these
studies. An attempt will be made to protect mice against a lethal dose of
Ehrlich cells by immunizing the mice with the trisaccharide-protein
conjugate.
The appearance of cell surface laminin, which is expressed on stimulated
but not resident murine macrophages, will be quantified under various
conditions of stimulation using a lectin-enzyme conjugate.
Biosynthetic studies will include an investigation of the incorporation of
D-galactose and N-acetyl-D-glucosamine into the polylactosamineglycan that
forms part of the structure of these alpha-D-galactosyl-terminated
glycoproteins. We shall characterize an alpha-D-galactosidase present in
Ehrlich ascites tumor cells and that probably is involved in the
biodegradation of alpha-D-galactosyl-containing glycoproteins.
The localization of alpha-D-galactosyl-terminated glycoconjugates in a
variety of cells by electron microscopy will be conducted using a colloidal
gold complex of Griffonia simplicifolia I-B4 isolectin, a probe specific
for alpha-D-galactosyl end groups.
We shall also attempt to select and characterize a variant of Ehrlich
ascites tumor cells that lack alpha-D-galactosyl groups. (A)
这项研究代表了我们关于
某些动物细胞上存在的含α-D-D-半乳糖基糖蛋白
和组织。 我们将把注意力集中在两个的碳水化合物中
地下膜和细胞表面糖蛋白:层粘连蛋白和肠蛋白,
两者都包含α-D-半乳糖基端基。 相信层粘连蛋白
存在于高度转移细胞的表面上。 结构和
将对生物合成研究对碳水化合物残基进行
这些糖蛋白以及alpha-d-d-galactosyl终止
糖蛋白存在于Ehrlich肿瘤细胞的表面上。 纯化
已知碳水化合物结合特异性的凝集素,升高的抗体
反对鼠层粘连蛋白和针对三糖触觉的一部分
这些糖蛋白的结构将在这些结构中使用
研究。 将尝试保护小鼠免受致命剂量
ehrlich细胞通过用三糖蛋白免疫小鼠
共轭。
细胞表面层粘连蛋白的出现,该层蛋白在刺激上表达
但是,在各种
使用凝集素 - 酶结合物刺激条件。
生物合成研究将包括对掺入的研究
D-半乳糖和N-乙酰基-D-葡萄糖胺进入聚乳糖胺聚糖,
构成了这些α-D-半乳糖基终止的结构的一部分
糖蛋白。 我们将表征存在于
Ehrlich腹水肿瘤细胞,这可能与
含α-D-半乳糖基糖蛋白的生物降解。
Alpha-D-半乳糖基终止的糖缀合物的定位
电子显微镜将使用胶体进行各种细胞
格里富尼的黄金复合物I-B 4分离蛋白,特定于探针
用于α-D-半乳糖基端组。
我们还将尝试选择并表征Ehrlich的变体
缺乏α-D-半乳糖基群的腹水肿瘤细胞。 (一个)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRWIN J GOLDSTEIN其他文献
IRWIN J GOLDSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRWIN J GOLDSTEIN', 18)}}的其他基金
FERMENTER CRYOSTAT STERLIZER CENTRIFUGE & CELL COUNTER
发酵罐 低温恒温器 灭菌器 离心机
- 批准号:
3525317 - 财政年份:1987
- 资助金额:
$ 19.57万 - 项目类别:
相似国自然基金
细菌核糖体翻译延伸速率测定方法的改进
- 批准号:31700089
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Urine podocyte and podocyte GL3: novel screening tools for phenotype assessment and treatment efficacy in Fabry disease
尿液足细胞和足细胞 GL3:用于法布里病表型评估和治疗效果的新型筛选工具
- 批准号:
10644824 - 财政年份:2023
- 资助金额:
$ 19.57万 - 项目类别:
Rapid egg bioreactor construction for Fabry disease therapeutics
用于法布里病治疗的快速鸡蛋生物反应器构建
- 批准号:
10481061 - 财政年份:2022
- 资助金额:
$ 19.57万 - 项目类别:
Early Stage Studies of a Novel Positive Allosteric Modulator of the Alpha1-Adrenergic Receptor to Treat Alzheimer's Disease
新型α1-肾上腺素受体正变构调节剂治疗阿尔茨海默病的早期研究
- 批准号:
10380631 - 财政年份:2020
- 资助金额:
$ 19.57万 - 项目类别:
Proteome reprogramming by tRNA-cleaving toxins
通过 tRNA 裂解毒素进行蛋白质组重编程
- 批准号:
10112828 - 财政年份:2020
- 资助金额:
$ 19.57万 - 项目类别:
Early Stage Studies of a Novel Positive Allosteric Modulator of the Alpha1-Adrenergic Receptor to Treat Alzheimer's Disease
新型α1-肾上腺素受体正变构调节剂治疗阿尔茨海默病的早期研究
- 批准号:
10153647 - 财政年份:2020
- 资助金额:
$ 19.57万 - 项目类别: